Infrasonix

Infrasonix

Medical Devices, 1665 LKS Pkwy, Duluth, Georgia, 30043, United States, 1-10 Employees

infrasonix-inc.com

  • facebook
  • LinkedIn

Who is INFRASONIX

Infrasonix, Inc. is a Georgia corporation formed in January of 2015 engaged in the business of innovating medical devices, with core competence in the fast tracking of products from resea...

Read More

map
  • 1665 LKS Pkwy, Duluth, Georgia, 30043, United States Headquarters: 1665 LKS Pkwy, Duluth, Georgia, 30043, United States
  • 2015 Date Founded: 2015
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3841

checked-icon Does something look wrong? Fix it. | View contact records from INFRASONIX

Infrasonix Org Chart and Mapping

Employees

Nigel Flynn

Chairman and President

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Infrasonix

Answer: Infrasonix's headquarters are located at 1665 LKS Pkwy, Duluth, Georgia, 30043, United States

Answer: Infrasonix's official website is https://infrasonix-inc.com

Answer: Infrasonix's revenue is Under $1 Million

Answer: Infrasonix's SIC: 3841

Answer: Infrasonix has 1-10 employees

Answer: Infrasonix is in Medical Devices

Answer: Infrasonix contact info: Phone number: Website: https://infrasonix-inc.com

Answer: Infrasonix, Inc. is a Georgia corporation formed in January of 2015 engaged in the business of innovating medical devices, with core competence in the fast tracking of products from research and development to commercialization. The initial focus of the company is to evaluate an important disruptive medical technology created by a world famous public technology development organization in order to establish its efficacy. The company will then create additional intellectual property to protect its interests, and conclude a global licensing agreement with the licensor, to facilitate the domestic and international marketing and sale of product(s) derived from the technology. The technology is a completely new generation of detection technology which is believed to be capable of earlier identification and quantifying of the extent of cardiovascular disease states in subjects during a routine annual physical exam. It is also predicted that this technology will be capable of providing valuable information of importance to other disease states to be identified.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access